Skip to main content

Choate Investment Advisors

SEC CIK
0001399794
Latest filing
Aug 11, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Choate Investment Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
81,098
Value
$7.34M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Choate Investment Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202681,098$7.34M0.1%−15,963−16.4%ReducedHolders
Q1 202697,061$7.77M0.2%−10,866−10.1%ReducedHolders
Q4 2025107,927$9.20M0.2%−4,402−3.9%ReducedHolders
Q3 2025112,329$8.74M0.2%−8,172−6.8%ReducedHolders
Q2 2025120,501$9.42M0.2%−3,535−2.8%ReducedHolders
Q1 2025124,036$8.99M0.2%−5,321−4.1%ReducedHolders
Q4 2024129,357$9.57M0.2%−20,624−13.8%ReducedHolders
Q3 2024149,981$9.90M0.3%−2,738−1.8%ReducedHolders
Q2 2024152,719$14.1M0.4%−979−0.6%ReducedHolders
Q1 2024153,698$14.7M0.4%+2,117+1.4%AddedHolders
Q4 2023151,581$11.6M0.4%+144,264+1,971.6%AddedHolders
Q3 20237,317$506.9K<0.1%+978+15.4%AddedHolders
Q2 20236,339$598.0K<0.1%+527+9.1%AddedHolders
Q1 20235,812$480.8K<0.1%−36−0.6%ReducedHolders
Q4 20225,848$436.3K<0.1%−2,475−29.7%ReducedHolders
Q3 20228,323$688.0K<0.1%00.0%UnchangedHolders
Q2 20228,323$791.0K<0.1%+3,854+86.2%AddedHolders
Q1 20224,469$526.0K<0.1%−97−2.1%ReducedHolders
Q4 20214,566$592.0K<0.1%+133+3.0%AddedHolders
Q3 20214,433$502.0K<0.1%−30−0.7%ReducedHolders
Q2 20214,463$462.0K<0.1%−930−17.2%ReducedHolders
Q1 20215,393$451.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.